Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation.

PubWeight™: 2.43‹?› | Rank: Top 2%

🔗 View Article (PMC 2184278)

Published in J Exp Med on May 01, 1978

Authors

G Trinchieri, D Santoli, R R Dee, B B Knowles

Articles citing this

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med (1978) 4.86

Type I interferon: friend or foe? J Exp Med (2010) 4.40

Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli. Infect Immun (1991) 4.18

Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells. J Exp Med (1983) 2.93

Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med (1992) 2.71

Production of type I interferons: plasmacytoid dendritic cells and beyond. J Exp Med (2005) 2.14

HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells. Proc Natl Acad Sci U S A (2007) 2.01

Transcriptional programming of the dendritic cell network. Nat Rev Immunol (2012) 1.70

Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev (2008) 1.68

Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphcoytes. J Exp Med (1980) 1.48

Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor. Clin Exp Immunol (1980) 1.47

Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis. Proc Natl Acad Sci U S A (1979) 1.47

Interleukin 2 enhances natural killer cell activity through induction of gamma interferon. Infect Immun (1983) 1.45

Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. Blood (2011) 1.45

The role of type I interferon production by dendritic cells in host defense. Biochimie (2007) 1.33

Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis. Clin Exp Immunol (1981) 1.32

Multiple activities of a cloned cell line mediating natural killer cell function. J Exp Med (1981) 1.31

Augmentation of mouse natural killer activity and induction of interferon by tumor cells in vivo. J Exp Med (1980) 1.23

Gamma interferon induction in human thymocytes activated by lectins and B cell lines. Infect Immun (1982) 1.23

Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system? Nat Rev Immunol (2011) 1.23

Ikaros is required for plasmacytoid dendritic cell differentiation. Blood (2006) 1.22

Enhancement of human natural cell-mediated cytotoxicity by interferon. Br J Cancer (1980) 1.11

Innate immune response of the human host to exposure with herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction. J Virol (2000) 1.07

Human B lymphocytes produce leukocyte interferon after interaction with foreign cells. Infect Immun (1981) 1.02

Studies of the function of natural killer-interferon system in patients with Sjögren syndrome. J Clin Invest (1982) 0.99

Activating killer cell Ig-like receptors in health and disease. Front Immunol (2014) 0.95

Deficient natural killer cell activity in a patient with Fanconi's anaemia and squamous cell carcinoma. Association with defect in interferon release. Clin Exp Immunol (1982) 0.93

Myeloid dendritic cells (DCs) of mice susceptible to paracoccidioidomycosis suppress T cell responses whereas myeloid and plasmacytoid DCs from resistant mice induce effector and regulatory T cells. Infect Immun (2013) 0.90

Phenotype of human alpha-interferon producing leucocytes identified by monoclonal antibodies. Clin Exp Immunol (1983) 0.89

Reduced number of natural killer cells in patients with pathological hyperprolactinemia. Clin Exp Immunol (1986) 0.88

Medullasin enhances human natural killer cell activity. J Clin Invest (1982) 0.87

Insensitivity to interferon of NK cells from patients with systemic lupus erythematosus. Clin Exp Immunol (1982) 0.87

TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes. J Leukoc Biol (2011) 0.84

The role of dendritic cells in tissue-specific autoimmunity. J Immunol Res (2014) 0.84

Target selectivity of interferon-induced human killer lymphocytes related to their Fc receptor expression. Proc Natl Acad Sci U S A (1980) 0.84

Mechanism of stimulation of natural killer-cell cytotoxicity by interferon and an interferon-inducer in the rat. Immunology (1981) 0.83

In vitro stimulation of cell-mediated cytotoxicity by acute leukaemias. Br J Cancer (1981) 0.82

Plasmacytoid dendritic cells of the gut: relevance to immunity and pathology. Clin Immunol (2014) 0.82

Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity. Clin Dev Immunol (2009) 0.81

Transfer of interferon-induced viral resistance from human leukocytes to other cell types. Infect Immun (1980) 0.81

Potentiation of natural killer cell activity of human lymphocytes in vitro: the participation of interferon in stimulation with Staphylococcus aureus Cowan I bacteria but not with protein A. Immunology (1982) 0.80

Plasmacytoid dendritic cells in the duodenum of individuals diagnosed with myalgic encephalomyelitis are uniquely immunoreactive to antibodies to human endogenous retroviral proteins. In Vivo (2013) 0.79

In vitro enhancement of human natural cell-mediated cytotoxicity by purified influenza virus glycoproteins. J Virol (1984) 0.79

Natural killer cells in asthma. Front Immunol (2013) 0.78

Plasmacytoid Dendritic Cells: Neglected Regulators of the Immune Response to Staphylococcus aureus. Front Immunol (2014) 0.77

Modulation of the defective natural killer activity seen in thalassaemia major with desferrioxamine and alpha-interferon. Clin Exp Immunol (1987) 0.77

Effects of interferons on human B-cell differentiation in vitro. Korean J Intern Med (1987) 0.75

Effect of interferons on the inhibition of human natural killers by primary monolayer cell cultures. Immunology (1987) 0.75

Natural cell-mediated cytotoxicity of bovine mononuclear cells against virus-infected cells. Infect Immun (1982) 0.75

Transformed and normal cell surface glycoproteins that induce interferon production by nonsensitized lymphocytes. Infect Immun (1983) 0.75

Articles cited by this

A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44

Interaction of aggregated -globulin with B lymphocytes. J Exp Med (1972) 9.29

Studies on in vitro transformation by DNA and DNA fragments of human adenoviruses and simian virus 40. Cold Spring Harb Symp Quant Biol (1975) 7.76

Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res (1968) 7.53

Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer (1974) 6.53

Non-producer human cells induced by murine sarcoma virus. Int J Cancer (1975) 5.82

IgG on lymphocyte surfaces; technical problems and the significance of a third cell population. J Immunol (1975) 4.92

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med (1978) 4.86

Immune specific induction of interferon production in cultures of human blood lymphocytes. Science (1969) 4.43

Nonspecific acid esterase activity: a criterion for differentiation of T and B lymphocytes in mouse lymph nodes. Eur J Immunol (1975) 4.16

Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. J Immunol (1973) 3.88

Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science (1965) 3.40

Interferon appearance stimulated by endotoxin, bacteria, or viruses in mice pre-treated with Escherichia coli endotoxin or infected with Mycobacterium tuberculosis. Nature (1965) 3.34

Leukocytes and interferon in the host response to viral infections. II. Enhanced interferon response of leukocytes from immune animals. J Bacteriol (1966) 2.78

Lymphocyte interferon production and transformation after Herpes simplex infections in humans. J Immunol (1974) 2.64

Two antigenically distinct species of human interferon. Proc Natl Acad Sci U S A (1975) 2.59

Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. Proc Natl Acad Sci U S A (1972) 2.41

Enhancement of phagocytosis by interferon-containing preparations. Infect Immun (1971) 1.97

Interferon-stimulating and in vivo antiviral effects of various synthetic anionic polymers. Virology (1968) 1.96

Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon. J Exp Med (1977) 1.73

Selective increase in lymphocyte interferon response to vaccinia antigen after revaccination. Proc Natl Acad Sci U S A (1972) 1.73

Effects of interferon on antibody synthesis in vitro. J Immunol (1974) 1.73

Inhibition of 3H-thymidine incorporation of lymphocytes by a soluble factor from macrophages. Cell Immunol (1975) 1.65

Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62

HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans. J Immunol (1976) 1.54

Tumour cell lines induce interferon in human lymphocytes. Nature (1977) 1.50

Interferon preparations as modifiers of immune responses. Proc Soc Exp Biol Med (1972) 1.44

Identification of the cell multiplication inhibitory factors in interferon preparations as interferons. Nature (1976) 1.41

Interferon production in mixed lymphocyte cell cultures. Infect Immun (1971) 1.34

Some properties of virus and immune-induced human lymphocyte interferons. J Gen Virol (1972) 1.20

Antiviral and cell growth inhibitory activities reside in the same glycoprotein of human fibroblast interferon. Nature (1976) 1.18

Mouse leukemia: depression of serum interferon production. Science (1972) 1.15

Purification and characterization of human leukocyte interferon components. J Biol Chem (1976) 1.14

Use of thyrotropin and cholera toxin to probe the mechanism by which interferon initiates its antiviral activity. Proc Natl Acad Sci U S A (1976) 1.14

Increased susceptibility of cells treated with interferon to the toxicity of polyriboinosinic-polyribocytidylic acid. Proc Natl Acad Sci U S A (1972) 1.11

Separation of antiviral activity of human interferon from cell growth inhibitory effect. Nature (1975) 1.10

Inhibition of 125IUdR incorporation by supernatants from macrophage and lymphocyte cultures: a cautionary note. Cell Immunol (1976) 0.96

Murine leukemia: depressed response to interferon induction correlated with a serum hyporeactive factor. Infect Immun (1976) 0.94

Affinity chromatographic analysis of murine interferons induced by viruses and by T and B cell stimulants. Ann Immunol (Paris) (1977) 0.94

A comparative study of procedures for sheep erythrocyte-human-T-lymphocyte rosette formation. J Immunol Methods (1977) 0.93

Lymphocyte stimulation and interferon induction by 7 S anti-human lymphocyte globulins and their uni- and divalent fragments. Eur J Immunol (1972) 0.93

Characteristics of a human cell line successively transformed by Rous sarcoma virus and simian virus 40. J Natl Cancer Inst (1976) 0.90

Blocking of interferon production by chromatographically purified L cell interferon. Proc Soc Exp Biol Med (1973) 0.86

Antiviral and non-antiviral activity of highly purified interferon. Nat New Biol (1973) 0.86

Articles by these authors

Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science (1980) 13.44

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med (1989) 10.60

Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med (1993) 8.76

Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol (2001) 8.31

Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med (1993) 8.03

Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med (1991) 7.52

Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature (1979) 6.76

Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A (1978) 6.51

Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol (1995) 6.09

In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol (1996) 5.79

Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med (1984) 5.26

Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci U S A (1979) 4.98

Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. J Immunol (1983) 4.94

Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol (1994) 4.86

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med (1978) 4.86

Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med (1987) 4.54

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science (1994) 4.38

Immunosurgery of mouse blastocyst. Proc Natl Acad Sci U S A (1975) 4.33

The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med (1996) 3.82

Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol (1995) 3.76

Expression of Cre recombinase in mouse oocytes: a means to study maternal effect genes. Genesis (2000) 3.71

Mechanism of suppression of cell-mediated immunity by measles virus. Science (1996) 3.55

Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. Nat Immun Cell Growth Regul (1987) 3.45

Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones. J Exp Med (1994) 3.28

Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol (1996) 3.24

Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. J Immunol (1992) 3.15

Human natural killer cells: biologic and pathologic aspects. Lab Invest (1984) 2.99

Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells. J Exp Med (1983) 2.93

B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation. J Exp Med (1994) 2.85

Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med (1994) 2.82

The mouse rostral cerebellar malformation gene encodes an UNC-5-like protein. Nature (1997) 2.81

Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J (1983) 2.80

Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J Exp Med (1995) 2.80

Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J Exp Med (1988) 2.79

IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol (1995) 2.72

The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol (1984) 2.70

Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat Med (1995) 2.55

Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J Immunol (1987) 2.54

Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype. J Exp Med (1978) 2.54

Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane. J Immunol (1983) 2.37

Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10. J Exp Med (1996) 2.36

Stage-specific embryonic antigen involves alpha 1 goes to 3 fucosylated type 2 blood group chains. Nature (1981) 2.35

Gamma interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation. J Exp Med (1986) 2.33

Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med (1994) 2.29

Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor. J Immunol (1987) 2.24

Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon. J Exp Med (1986) 2.23

A leukocyte subset bearing HLA-DR antigens is responsible for in vitro alpha interferon production in response to viruses. Nat Immun Cell Growth Regul (1985) 2.17

Fc gamma R(CD16) interaction with ligand induces Ca2+ mobilization and phosphoinositide turnover in human natural killer cells. Role of Ca2+ in Fc gamma R(CD16)-induced transcription and expression of lymphokine genes. J Exp Med (1989) 2.16

Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J Exp Med (1993) 2.13

Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A (1991) 2.11

Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon. J Exp Med (1985) 2.11

New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J Biol Chem (1983) 2.08

Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol (1998) 2.05

Characterization of the asialoglycoprotein receptor in a continuous hepatoma line. J Biol Chem (1981) 2.04

A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8. J Immunol (1983) 2.04

CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin Immunol (1999) 2.01

Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction. J Exp Med (1994) 2.00

Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells. J Immunol (1978) 1.99

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest (1998) 1.93

Mechanisms of activation of human natural killer cells against tumor and virus-infected cells. Immunol Rev (1979) 1.88

Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J Immunol (1992) 1.88

Differential regulation of interleukin-12 (IL-12), tumor necrosis factor alpha, and IL-1 beta production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood (1994) 1.85

Human TCR-gamma+/delta+, CD8+ T lymphocytes recognize tetanus toxoid in an MHC-restricted fashion. J Exp Med (1989) 1.82

Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol (1996) 1.82

An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J Immunol (2000) 1.82

A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. J Exp Med (1995) 1.81

Genetic control of the cytotoxic T cell response to SV40 tumor-associated specific antigen. J Immunol (1979) 1.79

Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii. Infect Immun (1996) 1.79

Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines. Blood (1987) 1.77

The role of natural killer cells in host-parasite interactions. Curr Opin Immunol (1995) 1.77

Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells. J Immunol (1986) 1.75

Complement biosynthesis by the human hepatoma-derived cell line HepG2. J Clin Invest (1982) 1.75

Timely translation during the mouse oocyte-to-embryo transition. Development (2000) 1.75

Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HL-A. Transplant Proc (1973) 1.75

Interleukin-12 production by human polymorphonuclear leukocytes. Eur J Immunol (1995) 1.75

Antibody 3G8, specific for the human neutrophil Fc receptor, reacts with natural killer cells. J Immunol (1984) 1.75

The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. Blood (1999) 1.74

Tumor necrosis factor and immune interferon synergistically induce cytochrome b-245 heavy-chain gene expression and nicotinamide-adenine dinucleotide phosphate hydrogenase oxidase in human leukemic myeloid cells. J Clin Invest (1989) 1.73

Molecular basis of interferon-gamma and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components. J Biol Chem (1990) 1.71

Spontaneous cell-mediated cytotoxicity in humans: role of interferon and immunoglobulins. J Immunol (1978) 1.71

Interferon production by human and murine lymphocytes in response to alloantigens. J Immunol (1980) 1.70

Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway. J Exp Med (1983) 1.69

IL-12 enhances Th1-type responses in human Leishmania donovani infections. J Immunol (1995) 1.69

Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J Immunol (1997) 1.68

Production of hematopoietic colony-stimulating factors by human natural killer cells. J Exp Med (1989) 1.67

A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int J Cancer (1980) 1.63

Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts. J Exp Med (1986) 1.63

Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function. Adv Cancer Res (1984) 1.62

Human thymus contains IFN-alpha-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells. J Clin Invest (2001) 1.61

Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J Immunol (1997) 1.61

Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B. J Biol Chem (2000) 1.60

Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell (1982) 1.59

Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte. J Immunol (1978) 1.58